Aptiv Shorts Build as Analysts Slash Targets After Earnings Miss

Aptiv reported Q3 results on November 3, fell 6.5% the same day, and emerged with every major analyst cutting targets on November 4, yet almost none dropping their buy-equivalent ratings, a tension that defines the stock's position right now.

The analyst response to the print was unanimous in one direction: lower targets. Goldman Sachs cut to $54 from $61 while keeping Buy. Barclays trimmed to $53 from $60, holding Overweight. Morgan Stanley, the most cautious of the group, lowered to $45 from $55 on its Equal-Weight. RBC took the largest trim, moving to $64 from $77. TD Cowen stayed at Buy with a $72 target, down from $77. Even BNP Paribas reiterated Outperform with a $59 target, down from $63. The pattern is consistent: firms are acknowledging the miss while refusing to abandon the thesis. The mean price target, now around $65, still implies roughly 55% upside from the $41.34 close, a gap that reflects either deep conviction in a recovery or a Street that hasn't yet fully reckoned with how far the stock has fallen. At $41, Aptiv trades at roughly 6.6x trailing earnings and 6.3x EV/EBITDA, valuation deep enough that earnings yield ranks in the 85th percentile of the broader universe.

The bull case rests on Aptiv's positioning in electrification, automation and the diversification away from pure auto exposure. The bear case, articulated clearly in the data, is that automotive still dominates revenues, and a demand slowdown hits disproportionately hard before the pivot pays off. The company spun off Versigent and continues restructuring, but that takes time. Forward EPS recovery is still expected to be dramatic enough to rank in the 88th percentile on 12-month forward EPS year-on-year growth, yet recent EPS momentum scores, at 45 on a 30-day basis and 40 over 90 days, are both below the midpoint, suggesting estimate cuts have been outpacing upgrades.

Short interest is building but is not yet at the level that dominates the narrative. Shorts have risen 29% over the past month to roughly 4.4% of free float, with another 5.5% added in the past week alone. That is a meaningful acceleration, particularly concentrated around the earnings event. Despite the build, the lending market is loose: availability is at around 3,157% of outstanding short interest, meaning shares to borrow are plentiful and cost to borrow remains low at 0.56%. There is no squeeze dynamic here. The short score of 36.7 is creeping up, from roughly 34 two weeks ago, but remains well below levels that would signal any structural squeeze pressure. Options positioning is slightly more defensive than recent averages, with the put/call ratio at 0.41, about 1.5 standard deviations above its 20-day mean of 0.40. That is a modest tilt toward protection rather than a dramatic hedging signal.

One ownership feature worth noting is the August insider-buying cluster. CEO Kevin Clark purchased 51,190 shares at around $48.89 on August 10, spending roughly $2.5 million. Director Paul Meister bought 105,631 shares at $47.33, a commitment just under $5 million. Director Hakan Agnevall and Director Sean Mahoney also bought in August, the latter across three separate transactions. None of these trades were made under a 10b5-1 plan, making them discretionary purchases. That cluster was filed with the SEC in August, with the stock since declining a further 15% to current levels. Among the larger passive holders, Barrow Hanley filed a fresh 13G in August disclosing a 5.1% stake, and BlackRock updated its filing in late October at 6.0%. No 13D activists are on the register; all filings are passive 13G disclosures, subject to the usual caveat that stakes are as last disclosed around the 5% threshold.

The next earnings event is scheduled for February 4, 2027, giving the stock roughly three months before the next print. What to watch in the interim is whether the analyst target-cut cycle continues, whether short interest consolidates around the post-earnings level or keeps building, and whether the insider purchases from $47 to $50 in August prove to be the floor or simply early.